Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE089A01023 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Dr Reddys Labo Dr Reddys Laboratories Ltd. | BSE 4659.45 -8.25 (-0.18%) | NSE 4662.70 -3.50 (-0.08%) | Trade | Add

BSE Live

Oct 27, 16:00

4659.45 -8.25 (-0.18%)

Volume

AVERAGE VOLUME

5-Day

10,134

10-Day

24,821

30-Day

41,047

10,962

Prev. Close

4667.70
Open Price

4657.00

Bid Price (Qty.)
4665.00 (2)
Offer Price (Qty.)
4675.00 (6)

NSE Live

Oct 27, 15:59

4662.70 -3.50 (-0.08%)

Volume

AVERAGE VOLUME

5-Day

362,897

10-Day

353,761

30-Day

398,639

385,808

Prev. Close

4666.20
Open Price

4655.50

Bid Price (Qty.)
4662.70 (438)
Offer Price (Qty.)
0.00 (0)

Financials

Download Annual Report in PDF format 2020 2019 2018 2017 2016

Print/Copy to Excel : Go

Half Yearly Results of Dr Reddys Laboratories (in Rs. Cr.)	Mar '21	Sep '20	Mar '20	Sep '19	Mar '19
Net Sales/Income from operations	6,758.90	6,570.40	5,881.90	5,954.70	5,312.10
Other Operating Income	--	19.80	13.80	--	64.80
Total Income From Operations	6,758.90	6,590.20	5,895.70	5,954.70	5,376.90
EXPENDITURE
Consumption of Raw Materials	1,661.60	1,604.70	1,327.30	1,229.20	1,069.40
Purchase of Traded Goods	647.70	604.60	572.20	545.00	494.00
Increase/Decrease in Stocks	-66.90	-328.70	-32.90	-67.00	81.20
Power & Fuel	--	--	--	--	--
Employees Cost	1,117.10	1,153.00	1,027.80	1,002.40	961.90
Depreciation	423.10	411.90	388.10	401.10	397.70
Excise Duty	--	--	--	--	--
Admin. And Selling Expenses	--	1,799.30	--	--	--
R & D Expenses	--	--	--	--	--
Provisions And Contingencies	--	--	--	--	--
Exp. Capitalised	--	--	--	--	--
Other Expenses	2,022.50	--	1,724.80	1,653.60	1,646.90
P/L Before Other	953.80	1,345.40	888.40	1,190.40	725.80
Other Income	144.40	659.30	196.70	548.10	165.50
P/L Before Int.	1,098.20	2,004.70	1,085.10	1,738.50	891.30
Interest	23.40	23.30	23.50	24.30	24.50
P/L Before Exceptional Items & Tax	1,074.80	1,981.40	1,061.60	1,714.20	866.80
Exceptional Items	--	--	--	--	--
P/L Before Tax	1,074.80	1,981.40	1,061.60	1,714.20	866.80
Tax	319.60	550.20	37.10	-199.00	264.60
P/L After Tax from Ordinary Activities	755.20	1,431.20	1,024.50	1,913.20	602.20
Prior Year Adjustments	--	--	--	--	--
Extra Ordinary Items	--	--	--	--	--
Net Profit/(Loss) For the Period	755.20	1,431.20	1,024.50	1,913.20	602.20
Equity Share Capital	83.20	83.10	83.10	83.10	83.00
Reserves Excluding Revaluation Reserves	--	--	--	--	--
Equity Dividend Rate (%)	--	--	--	--	--
EPS Before Extra Ordinary
Basic EPS	45.38	86.31	61.64	115.42	--
Diluted EPS	--	86.08	--	115.21	--
EPS After Extra Ordinary
Basic EPS.	45.38	86.31	61.64	115.42	--
Diluted EPS.	--	86.08	--	115.21	--
Public Share Holding
No Of Shares (Crores)	--	--	--	--	--
Share Holding (%)	--	--	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--	--	--
b) Non-encumbered
- Number of shares (Crores).	--	--	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group).	--	--	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company).	--	--	--	--	--